{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:38:16Z","timestamp":1793655496479,"version":"4.5.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["4000502"],"award-info":[{"award-number":["4000502"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004481","name":"University of Tehran","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004481","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005243","name":"United Nations Educational, Scientific and Cultural Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijbiomac.2024.137728","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T15:03:18Z","timestamp":1731855798000},"page":"137728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"P2","title":["Differential scanning calorimetric domain dissection for HSA upon interaction with Bortezomib: Unveiling the binding dynamics"],"prefix":"10.1016","volume":"283","author":[{"given":"Bagher","family":"Davaeil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Saremipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faezeh","family":"Moosavi-Movahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Mohsen","family":"Asghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Akbar","family":"Moosavi-Movahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2024.137728_bb0005","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2165\/00003495-200969070-00006","article-title":"Bortezomib: a review of its use in patients with multiple myeloma","volume":"69","author":"Curran","year":"2009","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.137728_bb0010","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1039\/C4AY02368D","article-title":"Supercritical fluid (CO 2) chromatography for quantitative determination of selected cancer therapeutic drugs in the presence of potential impurities","volume":"7","author":"Ganipisetty","year":"2015","journal-title":"Anal. Methods"},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0305-7372(03)00081-1","article-title":"The proteasome: structure, function, and role in the cell","volume":"29","author":"Adams","year":"2003","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.137728_bb0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrd1959","article-title":"Success in translational research: lessons from the development of bortezomib","volume":"5","author":"S\u00e1nchez-Serrano","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.137728_bb0025","first-page":"3071","article-title":"The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells","volume":"61","author":"Hideshima","year":"2001","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.137728_bb0030","first-page":"2615","article-title":"Proteasome inhibitors: a novel class of potent and effective antitumor agents","volume":"59","author":"Adams","year":"1999","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.137728_bb0035","first-page":"1794","article-title":"Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignancies","volume":"104","author":"Ludwig","year":"2005","journal-title":"Cancer Interdiscip. Int. J. Am. Cancer Soc."},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0040","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/172458","article-title":"Mechanism of action of bortezomib and the new proteasome inhibitors on myeloma cells and the bone microenvironment: impact on myeloma-induced alterations of bone remodeling","volume":"2015","author":"Accardi","year":"2015","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.137728_bb0045","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd1279","article-title":"The IKK NF-kappa B system: a treasure trove for drug development","volume":"3","author":"Karin","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.137728_bb0050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/biom12010051","article-title":"Progress on the application of bortezomib and bortezomib-based nanoformulations","volume":"12","author":"Liu","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.137728_bb0055","first-page":"102","article-title":"Sensitizing human multiple myeloma cells to the proteasome inhibitor bortezomib by novel curcumin analogs","volume":"29","author":"Mujtaba","year":"2012","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.137728_bb0060","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/1078155210386268","article-title":"Stability of unused reconstituted bortezomib in original manufacturer vials","volume":"17","author":"Vanderloo","year":"2011","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0065","article-title":"Efficacy of bortezomib as first-line treatment for patients with multiple myeloma","volume":"7","author":"Painuly","year":"2013","journal-title":"Clin. Med. Insights: Oncol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.137728_bb0070","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1158\/1078-0432.CCR-03-0781","article-title":"Approval summary for bortezomib for injection in the treatment of multiple myeloma","volume":"10","author":"Bross","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0075","series-title":"Annual Reports in Medicinal Chemistry","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0065-7743(08)60472-8","article-title":"Plasma protein binding of drugs","author":"Olson","year":"1996"},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0080","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ijbiomac.2018.11.053","article-title":"Structure, enzymatic activities, glycation and therapeutic potential of human serum albumin: a natural cargo","volume":"123","author":"Rabbani","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0085","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jconrel.2015.06.006","article-title":"The role of albumin receptors in regulation of albumin homeostasis: implications for drug delivery","volume":"211","author":"Bern","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0090","series-title":"All About albumin: Biochemistry, Genetics, and Medical Applications","author":"Peters","year":"1995"},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.137728_bb0095","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2174\/0929867023369673","article-title":"Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance","volume":"9","author":"Bertucci","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1423-0410.2002.tb05326.x","article-title":"Beyond expansion: structural studies on the transport roles of human serum albumin","volume":"83","author":"Curry","year":"2002","journal-title":"Vox Sang."},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0105","first-page":"1","article-title":"Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis","volume":"5","author":"Wunder","year":"2003","journal-title":"Arthritis Res. Therap."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.137728_bb0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijbiomac.2005.05.005","article-title":"A differential scanning calorimetric study of the influence of copper and dodecyl trimethyl ammonium bromide on the stability of bovine \u03b1-lactalbumin","volume":"36","author":"Housaindokht","year":"2005","journal-title":"Int. J. Biol. Macromol."},{"issue":"37","key":"10.1016\/j.ijbiomac.2024.137728_bb0115","doi-asserted-by":"crossref","first-page":"13411","DOI":"10.1073\/pnas.0405724101","article-title":"Ultrafast hydration dynamics in protein unfolding: human serum albumin","volume":"101","author":"Kamal","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0120","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3389\/fimmu.2014.00682","article-title":"Unraveling the interaction between FcRn and albumin: opportunities for design of albumin-based therapeutics","volume":"5","author":"Sand","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.addr.2018.07.011","article-title":"Harnessing albumin as a carrier for cancer therapies","volume":"130","author":"Hoogenboezem","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2036.16.s5.2.x","article-title":"albumin as a drug\u2014biological effects of albumin unrelated to oncotic pressure","volume":"16","author":"Evans","year":"2002","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.137728_bb0135","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1016\/S0021-9258(17)40797-6","article-title":"On the relationship of fatty acid and bilirubin binding sites and the nature of fatty acid allosteric effects\u2014a monoanionic spin label study","volume":"253","author":"Soltys","year":"1978","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.137728_bb0140","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3390\/biom9110705","article-title":"Conformation and aggregation of human serum albumin in the presence of green tea polyphenol (EGCg) and\/or palmitic acid","volume":"9","author":"Sun","year":"2019","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.137728_bb0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural basis of the drug-binding specificity of human serum albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.137728_bb0150","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1021\/jm2010332","article-title":"Rational approaches to improving selectivity in drug design","volume":"55","author":"Huggins","year":"2012","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.137728_bb0155","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1080\/07391102.2015.1071280","article-title":"Probing the biological evaluations of a new designed Pt (II) complex using spectroscopic and theoretical approaches: Human hemoglobin as a target","volume":"34","author":"Abazari","year":"2016","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0160","series-title":"Princ. Fluoresc. Spectrosc","author":"Lakowicz","year":"2006"},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0165","series-title":"Principles of fluorescence spectroscopy","author":"Lakowicz","year":"1999"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.137728_bb0170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1017\/S0022029909990367","article-title":"Comparative study on heat stability of camel and bovine apo and holo \u03b1-lactalbumin","volume":"77","author":"Atri","year":"2010","journal-title":"J. Dairy Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.137728_bb0175","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/protein\/5.3.191","article-title":"Quantitative analysis of protein far UV circular dichroism spectra by neural networks","volume":"5","author":"B\u00f6hm","year":"1992","journal-title":"Protein Eng. Des. Sel."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.137728_bb0180","first-page":"1010","article-title":"HyperChem: a software package for computational chemistry and molecular modeling","volume":"14","author":"Froimowitz","year":"1993","journal-title":"Biotechniques"},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.137728_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6","article-title":"Automated docking of flexible ligands: applications of AutoDock","volume":"9","author":"Goodsell","year":"1996","journal-title":"J. Mol. Recognit."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.137728_bb0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1995","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0195","series-title":"PyMOL Molecular Graphics System; Version 2.5;Schr\u00f6dinger Release 2022-3: LigPrep, Schr\u00f6dinger, LLC: New York, NY, USA","author":"Schr\u00f6dinger","year":"2021"},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.137728_bb0200","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/jcc.1078","article-title":"An improved GROMOS96 force field for aliphatic hydrocarbons in the condensed phase","volume":"22","author":"Schuler","year":"2001","journal-title":"J. Comput. Chem."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.137728_bb0205","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1021\/ct200196m","article-title":"An automated force field topology builder (ATB) and repository: version 1.0","volume":"7","author":"Malde","year":"2011","journal-title":"J. Chem. Theory Comput."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.137728_bb0210","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"issue":"14","key":"10.1016\/j.ijbiomac.2024.137728_bb0215","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1103\/PhysRevLett.45.1196","article-title":"Crystal structure and pair potentials: a molecular-dynamics study","volume":"45","author":"Parrinello","year":"1980","journal-title":"Phys. Rev. Lett."},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0220","series-title":"DNA-Protein Interactions: A Practical Approach","author":"Travers","year":"2000"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.137728_bb0225","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0006-3495(98)77598-8","article-title":"Unfolding of acrylodan-labeled human serum albumin probed by steady-state and time-resolved fluorescence methods","volume":"75","author":"Flora","year":"1998","journal-title":"Biophys. J."},{"issue":"26","key":"10.1016\/j.ijbiomac.2024.137728_bb0230","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1021\/jp5030944","article-title":"Temperature induced morphological transitions from native to unfolded aggregated states of human serum albumin","volume":"118","author":"Das","year":"2014","journal-title":"J. Phys. Chem. B"},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.137728_bb0235","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1021\/acs.molpharmaceut.7b00976","article-title":"Binding of tolperisone hydrochloride with human serum albumin: effects on the conformation, thermodynamics, and activity of HSA","volume":"15","author":"Rabbani","year":"2018","journal-title":"Mol. Pharm."},{"issue":"01","key":"10.1016\/j.ijbiomac.2024.137728_bb0240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4236\/jbpc.2016.71002","article-title":"Effects of selective biotinylation on the thermodynamic stability of human serum albumin","volume":"7","author":"Hoang","year":"2016","journal-title":"J. Biophys. Chem."},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0245","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.physchem.56.092503.141202","article-title":"Heat capacity in proteins","volume":"56","author":"Prabhu","year":"2005","journal-title":"Annu. Rev. Phys. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.137728_bb0250","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jmb.2006.06.028","article-title":"Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis","volume":"361","author":"Simard","year":"2006","journal-title":"J. Mol. Biol."},{"issue":"3\u20134","key":"10.1016\/j.ijbiomac.2024.137728_bb0255","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jpba.2005.04.009","article-title":"Fluorometric investigation of the interaction between methylene blue and human serum albumin","volume":"39","author":"Hu","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0260","article-title":"Exploring the binding mechanism and esterase-like activity of human serum albumin with levofloxacin and its choline based conjugates: a biophysical approach","volume":"133011","author":"Bhat","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.137728_bb0265","doi-asserted-by":"crossref","first-page":"22518","DOI":"10.3390\/ijms151222518","article-title":"Intrinsic tryptophan fluorescence in the detection and analysis of proteins: a focus on F\u00f6rster resonance energy transfer techniques","volume":"15","author":"Ghisaidoobe","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.137728_bb0270","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bbapap.2007.06.008","article-title":"Aggregation and fibrillation of bovine serum albumin","volume":"1774","author":"Holm","year":"2007","journal-title":"Biochim. Biophys. Acta (BBA)-Prot. Proteom."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.137728_bb0275","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0167-4838(96)00221-X","article-title":"Probing the cysteine 34 residue in human serum albumin using fluorescence techniques","volume":"1338","author":"Narazaki","year":"1997","journal-title":"Biochim. Biophys. Acta (BBA)-Protein Struct. Molec. Enzymol."},{"key":"10.1016\/j.ijbiomac.2024.137728_bb0280","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.ijbiomac.2017.04.051","article-title":"Binding of erucic acid with human serum albumin using a spectroscopic and molecular docking study","volume":"105","author":"Rabbani","year":"2017","journal-title":"Int. J. Biol. Macromol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024085386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024085386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T18:44:30Z","timestamp":1740768270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024085386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":56,"alternative-id":["S0141813024085386"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.137728","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential scanning calorimetric domain dissection for HSA upon interaction with Bortezomib: Unveiling the binding dynamics","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.137728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"137728"}}